Other

Cash and Cash Equivalents and Debt Securities, Available-for-sale, Fair Value

Intuitive Surgical Cash and Cash Equivalents and Debt Securities, Available-for-sale, Fair Value decreased by 11.7% to $7.98B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.3%, from $9.10B to $7.98B. Over 5 years (FY 2020 to FY 2025), Cash and Cash Equivalents and Debt Securities, Available-for-sale, Fair Value shows an upward trend with a 5.6% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2017
Last reportedQ1 2026Apr 22, 2026
Metric ID: other_cashand_cash_equivalentsand_debt_securities_availa_36e9bf

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$7.73B$8.22B$8.62B$8.40B$8.18B$7.39B$6.74B$6.58B$7.13B$7.52B$7.34B$7.32B$7.68B$8.31B$8.83B$9.10B$9.53B$8.43B$9.03B$7.98B
QoQ Change—+6.3%+4.9%-2.5%-2.7%-9.6%-8.8%-2.4%+8.4%+5.5%-2.4%-0.3%+4.9%+8.2%+6.3%+3.0%+4.7%-11.5%+7.1%-11.7%
YoY Change————+5.7%-10.1%-21.8%-21.7%-12.8%+1.7%+8.9%+11.3%+7.7%+10.5%+20.3%+24.3%+24.1%+1.5%+2.3%-12.3%
Range$6.58B – $9.53B
CAGR+0.7%
Avg YoY Growth+2.5%
Median YoY Growth+4.0%

Frequently Asked Questions

What is Intuitive Surgical's cash and cash equivalents and debt securities, available-for-sale, fair value?
Intuitive Surgical (ISRG) reported cash and cash equivalents and debt securities, available-for-sale, fair value of $7.98B in Q1 2026.
How has Intuitive Surgical's cash and cash equivalents and debt securities, available-for-sale, fair value changed year-over-year?
Intuitive Surgical's cash and cash equivalents and debt securities, available-for-sale, fair value decreased by 12.3% year-over-year, from $9.10B to $7.98B.
What is the long-term trend for Intuitive Surgical's cash and cash equivalents and debt securities, available-for-sale, fair value?
Over 5 years (2020 to 2025), Intuitive Surgical's cash and cash equivalents and debt securities, available-for-sale, fair value has grown at a 5.6% compound annual growth rate (CAGR), from $6.87B to $9.03B.